欧美日韩国产综合草草丨久久99精品久久久久久噜噜丨国产农村妇女野外牲交视频丨99精品热这里只有精品丨无码任你躁久久久久久

Home>About Livzon>Company Profile

Profile of Zhuhai Livzon Diagnostics Inc.
Zhuhai Livzon Diagnostics Inc. (hereinafter referred to as “Livzon Diagnostics”) was established in 1989. It is the first high-tech subsidiary of the listed company, Livzon Pharmaceutical Group (A-share and H-share listed company), who specializing in in-vitro diagnostics in research, developing, manufacturing and marketing of diagnosis products and automation equipment. Livzon Diagnostics is one of the earliest in vitro diagnostic products manufacturing enterprises in China, a national high-tech enterprise.

Livzon Diagnostics has established many technical platforms such as Enzyme-linked Immunoassay, lateral flow chromatography, Microorganisms testing, Molecular testing, Multiple-detection Immunoassay, Single-test Chemiluminescence immunoassay, Mast Cell Degranulation Test for Allergy, etc. Meanwhile, Livzon Diagnostics also has fully automatic equipment development capability. The products cover many disease areas such as infectious diseases, respiratory infection, tumor marker detection, drug concentration monitoring, autoimmunity, allergen detection, and blood safety. Therefore, Livzon Diagnostics has high market share in respiratory infections, infectious diseases, and drug concentration monitoring with market share as high as 50% -90%.

Zhuhai Livzon Diagnostics Inc.  has equipped with its industrialization base for Research and Development, Production and Office use, which covers an area of more than 23,000 square meters, construction area of more than 44,000 square meters, including 6000 square meters for Research and Development, which attracts professional elite talents from Laboratory Science, Biological engineering and many other fields. Zhuhai Livzon Diagnostics Inc. owns 5 Research and Development teams spread in 3 Research and Development centers, which located in Zhuhai, Shanghai and Suzhou city. The total Research and Development personnel accounted for nearly 20% , meanwhile the annual Research and Development investment reaches more than 10% of Sales Revenue. Beside its independent Research and Development, Zhuhai Livzon Diagnostics Inc. has established long-term successful cooperation with many first-class International Biomedical Enterprises such as Fujirebro from Japan, Siemens in Germany, and MP company (USA), which has enhanced its comprehensive service capabilities. Zhuhai Livzon Diagnostics Inc. has won the title of honor as "National High-tech Enterprises", "In vitro diagnostic Engineering Technology Research Center of Guangdong Province ", "Guangdong Provincial Enterprise Technology Center", "Innovative Enterprises of Guangdong Province " and the national "Post-doctoral Research Station". With a complete quality management system in production, Zhuhai Livzon Diagnostics Inc. has well achieved the national GMP certification, GSP certification and ISO13485/ISO9001 certification.
Livzon Overview
3
R&D centers
5
R&D teams
20%
scientific research personnel
50%
personnel with master degree
6000
R&D land area (m2)
作為中國IVD行業的先行者,麗珠試劑服務產品涵蓋了傳染性疾病、呼吸道感染、腫瘤標志物檢測、藥物濃度監測、自身免疫、過敏原檢測及血液安全等眾多領域,在呼吸道感染、傳染性疾病、藥物濃度監測等領域的市場占有率處于國內領先地位,多項產品市場占有率高達50%-90%。在2019年底中國爆發新型冠狀病毒的第一時間,麗珠試劑便投入研發,迅速研制出新型冠狀病毒(2019-nCoV)IgM / IgG抗體檢測試劑盒(膠體金法)產品,并獲證上市,助力國內外疫情防控。
  • 5.jpg

  • 6.jpg

Livzon Diagnostics Technology Theme Exhibition Hall
Focus on disease research · Create new detection technology

主站蜘蛛池模板: 蜜臀av无码一区二区三区| 成年美女看的黄网站色戒| 亚洲欧美乱综合图片区小说区| 人妻无码视频一区二区三区| 国产精品人妻99一区二区三区| 五十路熟妇强烈无码| 国产免费视频| 天堂а√中文在线官网| 国产艳妇av在线观看果冻传媒 | 国内精品乱码卡一卡2卡麻豆| 国产香蕉尹人在线视频你懂的| 亚洲gv猛男gv无码男同| 在线天堂免费观看.www| 亚洲日本va中文字幕| 国产又粗又黄又爽的大片| 成人试看120秒体验区| 三上悠亚福利一区二区| 蜜桃视频成人专区在线观看| 久久精品夜色噜噜亚洲a∨| 欧洲多毛裸体xxxxx| 女子spa高潮呻吟抽搐| 国产精品无码无卡在线播放| 别揉我奶头~嗯~啊~一区二区三区| 2020久久天天躁狠狠躁夜夜 | 国产毛a片啊久久久久久保和丸| 国产精品久久自在自线不卡| 久久久精品区二区三区免费| 在线va亚洲va天堂中文字幕| 国产午夜成人无码免费看不卡| 欧美freesex黑人又粗又大| 国语自产精品视频在线区| 精品国产乱码久久久久久1区2区| 玩弄人妻少妇精品视频| 亚洲色成人网站www永久下载| 亚洲精品国产av成拍色拍| 500av导航大全精品| 国产亚洲一卡2卡3卡4卡新区| 欧美人妻精品一区二区三区| 久久久久免费看成人影片| 伊人久久大香线蕉在观看| 欧美乱人伦视频在线观看|